Palantir Analyst Consensus Shifts Bullish, But Valuation Warrants Scrutiny

Palantir Technologies reports Q3 results on November 2, arriving at the print with a striking divergence: a wave of analyst upgrades and target lifts in the past three weeks, a stock that has barely moved, and a peer group running well ahead.

The analyst activity is the most notable development in the run-up. JP Morgan initiated with an Overweight rating and a $262 target on October 29. That came one day after Rosenblatt raised its target to $260 from $225, and a week after Barclays started coverage at Overweight with a $265 target. Oppenheimer lifted its target to $235, Citigroup to $250, and Goldman Sachs upgraded to Buy from Neutral on October 8. The direction of travel is one-sided: nearly every firm that has touched the stock in October has moved higher. Yet PLTR added just 0.1% over the past week against a peer median of 4.5%, and sits at $196.42 against a cluster of new targets in the $230 to $265 range. The market is not yet pricing in the analyst revision cycle.

The bull case rests on two pillars: the company's AI platforms are proving useful in real workflows, with the FAA Foundry deployment cited as evidence of durable government adoption, and commercial momentum has been strong, with revenue growth running well above 100% on the U.S. commercial side in the prior quarter. Bears counter that a small number of large contracts drive quarterly results, the commercial conversion from AIP bootcamps to scaled deployments is unproven at volume, and competition from Microsoft, Amazon, and Snowflake is intensifying. The valuation adds a third layer of friction: the trailing P/E is 88x and EV/EBITDA is 63x, both near the upper end of software peers. The prior quarter's print produced a 32% single-day move. That history sets a high bar for what the market will accept as "in line."

Insider activity offers a mild counterpoint to the analyst optimism. Director Alexander Moore sold roughly $3.1 million worth of shares across multiple tranches on October 15, all under a pre-arranged 10b5-1 plan. Other directors filed smaller planned sales in early October. Net insider selling over the past 90 days totals roughly $106 million, though the planned-trade designations reduce the informational weight of each transaction. Institutional holders including BlackRock and State Street added shares through September 30, providing a more conventional demand signal.

Short positioning is not a material factor at this level. Short interest has drifted up 7% over the past week to roughly 2.6% of the free float, recovering from a 30-day low, but the absolute level is modest and borrow availability is extraordinarily loose at nearly 8,900% of short interest. Cost to borrow is 0.26%, well off the very low October readings. There is no squeeze pressure and no structural constraint on new shorts or new buyers.

The November 2 print will test whether the company's Q3 revenue and commercial pipeline figures justify the gap between a $196 stock and a sell-side consensus that has moved decisively above $230.